Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Artiva Biotherapeutics, Inc.ARTV · Entity 5404 | Director | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Artiva Biotherapeutics, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.42 · Expires 2036-09-09 | Direct | 16,250 |
Reported balance
After 2026-09-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-10 · Grant · Acquired 16,250 · Balance 16,250 F1: The shares subject to the option will vest in full on the earlier of September 10, 2027, or the date of the Issuer's 2027 annual stockholder meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in full on the earlier of September 10, 2027, or the date of the Issuer's 2027 annual stockholder meeting.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BRISTOL MYERS SQUIBB CO
Report date July 01, 2014 · Filed July 02, 2014
Section 16 reporting ended · disclosed 2014-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 94,374.041 |
Ending reported balance
After 2014-07-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2014-07-01 · Exercise / conversion · Acquired 4,671 · Balance 96,477.041 Row 2 · 2014-07-01 · Tax withholding · Disposed 2,103 · Balance 94,374.041 F1: Shares withheld for payment of taxes upon vesting of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,340 |
Reported balance
After 2014-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2014-07-01 · Exercise / conversion · Disposed 4,671 · Balance 9,340 F2: Each restricted stock unit converts into one share of common stock upon vesting. F3: Represents vesting of one-third of restricted stock units granted on July 1, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of taxes upon vesting of restricted stock units.
F2: Each restricted stock unit converts into one share of common stock upon vesting.
F3: Represents vesting of one-third of restricted stock units granted on July 1, 2011.
Cabaletta Bio, Inc.
Report date June 01, 2021 · Filed June 28, 2021 · Amendment
Section 16 reporting ended · disclosed 2021-06-28. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2031-05-31 | Direct | 0 |
Reported balance
After 2021-06-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-06-01 · Grant · Disposed 22,000 · Balance 0 F1: This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 14 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,029 Underlying: Common Stock, $0.10 par value · 3,009 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 13 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,219 Underlying: Common Stock, $0.10 par value · 3,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F2 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F2 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 12 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,031 Underlying: Common Stock, $0.10 par value · 3,703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F3 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 15,247 | $37.53 | $572,219.91 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 11 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,239.041 F7 · shares: Shares withheld for payment of taxes upon distribution of the 2010-2012 Long-Term Performance Award. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,122 | $37.53 | $79,638.66 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 10 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,486.041 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,987 | $37.53 | $74,572.11 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 9 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,608.041 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,276 | $37.53 | $47,888.28 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 8 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,595.041 F6 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 416 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 7 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,871.041 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,455.041 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,825.041 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,942.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,933.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,230.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 31,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,418.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award. Read SEC document |
| March 04, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 1,870 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · derivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 1,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. F3 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. Read SEC document |
| March 04, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 697 | $36.94 | $25,747.18 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · nonDerivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,872.041 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 04, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,569.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vesting of one-third of restricted stock units granted on March 4, 2008. This is the final vesting of this award. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,691 Underlying: Common Stock, $0.10 par value · 2,691 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. F1 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,002 | $37.15 | $37,224.30 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,699.041 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006655 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,701.041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| January 31, 2013 Filed Jan 31, 2013 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 12,000 | $36.22 | $434,640.00 |
DisclosureSEC source: 0001225208-13-002612 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010.041 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.20 to $36.27, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2012 Filed Aug 14, 2012 20:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 5,989 | $0.00 Strike: $23.14 | $0.00 |
DisclosureSEC source: 0001225208-12-017773 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,989 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2003. Read SEC document |
| August 10, 2012 Filed Aug 14, 2012 20:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionExecutive Option (right to buy) · Derivative | 71,556 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-12-017773 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,852 Underlying: Common Stock, $0.10 par value · 71,556 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, and third anniversaries of the grant date, which was March 3, 2009. The remainder of the stock option award will vest on March 3, 2013, the fourth anniversary of the grant date. Read SEC document |
| August 10, 2012 Filed Aug 14, 2012 20:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 79,900 | $31.72 | $2,534,428.00 |
DisclosureSEC source: 0001225208-12-017773 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,010 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.70 to $31.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2012 Filed Aug 14, 2012 20:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,989 | $23.14 | $138,585.46 |
DisclosureSEC source: 0001225208-12-017773 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2012 Filed Aug 14, 2012 20:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 71,556 | $17.51 | $1,252,945.56 |
DisclosureSEC source: 0001225208-12-017773 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherPerformance Shares · Derivative | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 9 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,719 Underlying: Common Stock, $0.10 par value · 461 shares Expires 2014-03-31 F15 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F16 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F15 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F15 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 10,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 8 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,258 Underlying: Common Stock, $0.10 par value · 10,258 shares Expires 2014-03-31 F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F14 · shares: Represents performance shares earned under the 2011-2013 Long Term Performance Award. F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F13 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 28,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 7 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,169.2287 Underlying: Common Stock, $0.10 par value · 28,073 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F11 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F12 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherPerformance Shares · Derivative | 910.4587 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,242.2287 Underlying: Common Stock, $0.10 par value · 910.4587 shares Expires not disclosed F9 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F10 · shares: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F9 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F9 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 10,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,331.77 Underlying: Common Stock, $0.10 par value · 10,010 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 10,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,321.77 Underlying: Common Stock, $0.10 par value · 10,678 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F6 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · balance_after: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 12,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · derivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,038 Underlying: Common Stock, $0.10 par value · 12,038 shares Expires 2016-03-06 F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 11,375 | $32.33 | $367,753.75 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,365 F2 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 28,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007125 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 1,870 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · derivative · entry 14 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870 Underlying: Common Stock, $0.10 par value · 1,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. F7 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 680 | $32.59 | $22,161.20 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 10 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,667 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 9 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents vesting of one-third of restricted stock units granted on March 4, 2008. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · derivative · entry 13 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,382 Underlying: Common Stock, $0.10 par value · 2,691 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. F5 · derivative.expiration_date: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 979 | $32.59 | $31,905.61 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 8 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,477 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 7 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · derivative · entry 12 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,734 Underlying: Common Stock, $0.10 par value · 3,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,831 | $32.59 | $59,672.29 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,765 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,596 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · derivative · entry 11 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,547 Underlying: Common Stock, $0.10 par value · 3,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F1 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,711 | $32.64 | $55,847.04 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,561 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,272 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006729 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document |
| July 01, 2011 Filed Jul 6, 2011 20:23 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 14,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-017736 · doc4.xml · derivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,011 Underlying: Common Stock, $0.10 par value · 14,011 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F2 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.